The etiology of mental retardation/developmental delay (MRDD) remains a challenge to geneticists and clinicians and can be correlated to environmental and genetic factors. Chromosomal aberrations are common causes of moderate to severe mental retardation and may represent 10% of these occurrences. Here we report the case of a boy with development delay, hypoplasia of corpus callosum, microcephaly, muscular hypotonia, and facial dysmorphisms. A deletion of 7q36.1 → 36.3 and duplication of 9p22.3 → 23 was detected as a result of an unbalanced translocation of paternal origin. Breakpoint delimitation was achieved with array comparative genomic hybridization assay. Additional multiplex ligation dependent probe amplification (MLPA) analyzes confirmed one copy loss of 7q36.3 region and one copy gain of 9p24.3 region. Patient resultant phenotype is consistent with the already described findings for both 7q deletion and 9p duplication syndromes.

No abstract

differentiation of embryonic stem cells in co-culture assays. These findings in conjunction with previous works which shows DPSCs can exercise neuroprotective and neurotrophic effects indicate they may be a feasible candidate for cellular therapy.

fIn this work, we demonstrate that the fosI gene encodes a predicted small protein with 134 amino acids and determines reduced susceptibility to fosfomycin. It raised the MIC from 0.125 to 6 g/ml when the pBRA100 plasmid was introduced into Escherichia coli TOP10 and to 16 g/ml when the gene was cloned into the pBC_SK(؊) vector and expressed in E. coli TOP10.

No abstract

No abstract